Pharmaceuticals unlikely to avoid a harsh Brexit

International policy leaders attending the Bio Pharma Ambition conference in Dublin Castle last week were addressed by Dr Lorraine Nolan, chief executive of Ireland’s Health Products Regulatory Authority and a member of the European Medical Agency (EMA).

Pharmaceuticals unlikely to avoid a harsh Brexit

By John Whelan

International policy leaders attending the Bio Pharma Ambition conference in Dublin Castle last week were addressed by Dr Lorraine Nolan, chief executive of Ireland’s Health Products Regulatory Authority and a member of the European Medical Agency (EMA).

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited